Document Detail


Internal exposure monitoring of 131I-radiopharmaceutical production workers in Iran.
MedLine Citation:
PMID:  12918795     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The programme and results of internal exposure monitoring of four individuals who have worked for 7 to 10 years in a 131I radiopharmaceutical production laboratory are described. The monitoring has been carried out using an in vivo thyroid measurement technique. The maximum and minimum average annual intakes of 131I received by the laboratory workers was 536 and 79 kBq, respectively. The highest estimated annual intake of 131I, incurred by one of the workers in a single year, was nearly 3.8 MBq. The mean values of the annual intakes by all the workers in their working periods in the laboratory was below the intake limits recommended by the ICRP.
Authors:
N Alirezazadeh; H Garshasbi; J Karimi Diba
Related Documents :
16147425 - Estimation of daily exposure to 4-hydroxy-2-alkenals in korean foods containing n-3 and...
7604395 - Long vs. short monitoring intervals for peach harvesters exposed to foliar azinphos-met...
8367695 - Urinary styrene in the biological monitoring of styrene exposure.
15461135 - Comparison of operator exposure for five different greenhouse spraying applications.
22554125 - A new quality of life scale for teenagers with food hypersensitivity.
15652945 - Lack of enteral nutrition--effects on the intestinal immune system.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Radiation protection dosimetry     Volume:  104     ISSN:  0144-8420     ISO Abbreviation:  Radiat Prot Dosimetry     Publication Date:  2003  
Date Detail:
Created Date:  2003-08-15     Completed Date:  2004-04-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8109958     Medline TA:  Radiat Prot Dosimetry     Country:  England    
Other Details:
Languages:  eng     Pagination:  173-6     Citation Subset:  IM    
Affiliation:
National Radiation Protection Department, Iranian Nuclear Regulatory Authority, PO Box 14155-4494, Tehran, Iran. n_alirezazadeh@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Body Burden
Drug Industry / standards
Humans
Iodine Radioisotopes / analysis*,  diagnostic use,  pharmacokinetics*,  therapeutic use
Iran
Occupational Exposure / analysis*,  standards
Radiation Dosage
Radiation Protection / methods*,  standards
Radiometry / methods*,  standards
Radiopharmaceuticals / agonists,  diagnostic use,  pharmacokinetics,  therapeutic use
Thyroid Gland / metabolism*
Chemical
Reg. No./Substance:
0/Iodine Radioisotopes; 0/Radiopharmaceuticals

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of a Monte Carlo method to calculate the average solid angle subtended by a detector to sour...
Next Document:  Percutaneous transvenous mitral commissurotomy in juvenile mitral stenosis.